U.S. Banks Stock News

NYSE:AIG
NYSE:AIGInsurance

Is AIG’s US$1.6 Billion AI-Driven Specialty Underwriting Bet with McGill Reshaping the Investment Case (AIG)?

On March 16, 2026, McGill and Partners announced a collaboration with American International Group to apply agentic artificial intelligence to manage capacity deployment in the subscription market, supported by AIG’s US$1.60 billion commitment to McGill’s specialty gross premiums written portfolio, representing 25% of AIG’s capacity. This partnership highlights how AIG is tying advanced AI tools directly to underwriting decisions and capital allocation, potentially reshaping how it...
NYSE:TE
NYSE:TEElectrical

Is It Time To Reassess T1 Energy (TE) After Its Sharp Share Price Swings

If you are wondering whether T1 Energy at US$4.17 is starting to look attractive or still carries hidden risks, the key is to line up its price against a few clear valuation checks. The share price has seen sharp swings, with a 253.4% return over the last year, while more recent periods show a 6.9% decline over 7 days, a 41.8% decline over 30 days, and a 46.8% decline year to date. Recent moves have put T1 Energy back on many watchlists, as investors reassess what the latest price action...
NYSE:SSB
NYSE:SSBBanks

How Strong Q4 Results And Expanded Buybacks At SouthState Bank (SSB) Have Changed Its Investment Story

In recent months, SouthState Bank reported Q4 2025 results that management described as strong, featuring earnings per share growth of more than 30%, double-digit tangible book value growth, an 11% dividend increase, and the repurchase of 2 million shares, alongside Board approval for an additional 5.56 million-share buyback authorization. While Tudor Investment Corp sharply reduced its position and some banks adjusted their research views, SouthState’s larger repurchase plan underscores...
NYSE:IFF
NYSE:IFFChemicals

How Investors Are Reacting To International Flavors & Fragrances (IFF) Expanding Microbiome and Soy Protein Health Claims

In early April 2026, International Flavors & Fragrances launched PureStrong, a single-strain canine probiotic, and gained Australia–New Zealand approval for a heart health claim on isolated soy protein, expanding its science-backed pet and human nutrition offerings. These developments highlight how IFF is using microbiome research and regulatory-backed soy protein science to deepen its presence in health-oriented, higher-value specialty ingredients across both pet care and food...
NasdaqGS:EA
NasdaqGS:EAEntertainment

EA SPORTS Gen Platform Links Young Athletes To EA Growth Story

EA SPORTS has launched GEN / EA SPORTS, a new platform focused on connecting emerging athletes and fans through content and culture. The company signed high school athlete Elijah Haven as its first official ambassador, a first for the brand. The move signals EA SPORTS' intent to invest in younger talent and deepen its role across sports and entertainment communities. For investors watching Electronic Arts, NasdaqGS:EA, this launch comes with the stock trading at $203.99 and a 1 year return...
NasdaqGS:CTSH
NasdaqGS:CTSHIT

Cognizant Court Win Clarifies Legal Risks And Potential Cash Upside

A US District Court issued a significant ruling in the longstanding Syntel v. Cognizant/TriZetto case. The court awarded Cognizant/TriZetto substantial compensatory and punitive damages, plus attorney fees and interest. The ruling confirms earlier jury findings of liability against Syntel and addresses litigation that has been ongoing since 2015. This legal outcome may affect Cognizant Technology Solutions' legal risk profile and could be relevant for investors watching...
NYSE:DRI
NYSE:DRIHospitality

Strong Q3 Beat and Insider Selling Could Be A Game Changer For Darden Restaurants (DRI)

Darden Restaurants recently reported fiscal third-quarter 2026 results that exceeded expectations, with management highlighting strong same-restaurant sales and an upbeat outlook on March performance. A series of executive share sales, including transactions by Group President Melvin John Martin and SVP Lindsay L. Koren, came alongside more optimistic commentary from analysts who raised their longer-term growth assumptions for the business. With third-quarter earnings topping expectations...
NYSE:BEKE
NYSE:BEKEReal Estate

A Look At KE Holdings (NYSE:BEKE) Valuation After Its AI Focused Growth Strategy Update

KE Holdings (BEKE) shares moved after the company used its fourth quarter results on March 16 to outline an efficiency focused growth plan centered on systematic service upgrades and broader use of AI technology. See our latest analysis for KE Holdings. At a latest share price of US$15.63, KE Holdings has seen a 2.9% 1 day share price return and 5.3% 7 day share price return, but this follows a 30 day share price return of 6.0% and a 1 year total shareholder return of 13.5% loss. This...
NYSE:CMC
NYSE:CMCMetals and Mining

Is Profit Turnaround And Aggressive Buyback Altering The Investment Case For Commercial Metals (CMC)?

In March 2026, Commercial Metals Company reported past second-quarter sales of US$2,132.02 million and net income of US$93.03 million, alongside six-month sales of US$4,252.33 million and net income of US$270.31 million, marking a clear turnaround from the prior year’s loss. Over the same period, the company also advanced its capital return efforts by completing a share repurchase of 15,131,239 shares for US$702.21 million, shrinking its share count and signaling confidence in its financial...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Liquidia’s L606 Puts New Focus On Pulmonary Hypertension Growth Story

Liquidia (NasdaqCM:LQDA) is drawing attention after its investigational drug L606 was highlighted as a potential transformative therapy in the interstitial lung disease market. The candidate targets patients facing pulmonary hypertension and related conditions, positioning L606 as a possible new standard of care if clinical development progresses successfully. For investors tracking biopharma, Liquidia focuses on therapies for pulmonary hypertension and related respiratory conditions, an...
NYSE:MCK
NYSE:MCKHealthcare

McKesson CFO Transition Puts Capital Allocation And Valuation In Focus

McKesson (NYSE:MCK) announced that EVP and CFO Britt Vitalone will retire. Kenny Cheung has been named incoming CFO, effective May 29, 2026. The transition shifts responsibility for McKesson's financial leadership and capital decisions to Cheung on that date. For investors watching McKesson at a share price of $871.18, this CFO change comes after a 1 year return of 30.2% and a 5 year gain of about 4.7x. The company has also recorded a 3 year return of 143.7%, while year to date performance...
NYSE:FDS
NYSE:FDSCapital Markets

New FactSet CFO Appointment Coincides With AI Push And Valuation Gap

FactSet Research Systems (NYSE:FDS) has appointed Joshua B. Warren as its new Chief Financial Officer, marking a key executive transition. The leadership change comes as FactSet rolls out new AI powered banking solutions and deepens its partnership with Finster AI. FactSet enters this CFO transition with NYSE:FDS trading at $222.97 and multi year returns that have been under pressure, including a 47.0% decline over the past year and a 24.2% decline over five years. For readers, that...
NYSE:WTTR
NYSE:WTTREnergy Services

Assessing Select Water Solutions (WTTR) Valuation After Strong Recent Share Price Performance

Select Water Solutions (WTTR) has drawn fresh attention after recent share price moves, with the stock last closing at $15.36. Investors are weighing this level against the company’s financial profile and water-focused energy services business. See our latest analysis for Select Water Solutions. Recent trading has added to a strong run, with a 10.34% 1 month share price return and a 36.65% 3 month share price return contributing to a 38.50% year to date share price gain. The 1 year total...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

How Investors Are Reacting To Alumis (ALMS) Psoriasis Drug’s Strong Phase 3 Data And Safety Profile

Alumis Inc. recently reported Phase 3 ONWARD1 and ONWARD2 data showing its oral TYK2 inhibitor envudeucitinib produced high rates of robust, durable skin clearance and quality-of-life improvements in adults with moderate-to-severe plaque psoriasis through Week 24, with a generally well-tolerated safety profile. An interesting aspect for investors is envudeucitinib’s maximal 24-hour TYK2 inhibition without fasting requirements, aiming to balance efficacy, convenience, and selective immune...
NasdaqGM:NMIH
NasdaqGM:NMIHDiversified Financial

Will NMI Holdings’ US$250 Million Buyback Through 2027 Change NMIH’s Investment Narrative?

NMI Holdings recently announced a US$250.00 million share repurchase program running through December 2027, following a period of consistent earnings outperformance and solid operating results that have strengthened investor confidence. This combination of disciplined capital returns and robust fundamental execution underscores management’s focus on enhancing shareholder value while reinforcing the company’s position in the private mortgage insurance market. With this sizeable buyback plan...
NasdaqGS:SOLS
NasdaqGS:SOLSChemicals

A Look At Solstice Advanced Materials (SOLS) Valuation After Hudson Technologies Licensing Agreement

Solstice Advanced Materials (SOLS) recently drew attention after Hudson Technologies signed a licensing agreement to reclaim and resell Solstice branded R-448A and R-449A refrigerants in the United States and Canada. See our latest analysis for Solstice Advanced Materials. Since early in the year, interest around Solstice Advanced Materials has lined up with stronger share price momentum, with a 90 day share price return of 59.95% and a year to date share price return of 69.14% alongside...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

3 Stocks That May Be Trading Below Their Estimated Intrinsic Value

The United States market has experienced a notable upswing, climbing 3.0% in the last week and rising 26% over the past year, with earnings projected to grow by 16% annually. In this context of robust market performance, identifying stocks that may be trading below their estimated intrinsic value could offer investors potential opportunities for growth and value appreciation.
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

3 Promising Growth Companies With Insider Ownership Up To 20%

The United States market has shown robust performance, with a 3.0% rise over the last week and a 26% increase over the past year, while earnings are anticipated to grow by 16% annually in the coming years. In this thriving environment, growth companies with significant insider ownership can be particularly appealing as they often reflect strong confidence from those closest to the business.
NYSE:NXDR
NYSE:NXDRInteractive Media and Services

April 2026 Penny Stocks With Growth Potential

The United States market has experienced a robust climb, rising 3.0% in the last week and 26% over the past year, with earnings projected to grow by 16% annually. In light of these conditions, identifying stocks with strong financials and growth potential is crucial for investors looking to capitalize on market opportunities. Although penny stocks may seem like an outdated term, they continue to represent smaller or newer companies that can offer significant value; this article highlights...
NYSEAM:BKTI
NYSEAM:BKTICommunications

Discovering US Undiscovered Gems In April 2026

The United States market has shown robust performance, climbing 3.0% in the last week and 26% over the past year, with earnings projected to grow by 16% annually. In this dynamic environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors looking to capitalize on emerging trends.
NasdaqGS:CTBI
NasdaqGS:CTBIBanks

April 2026's Noteworthy Dividend Stocks To Consider

The United States market has shown robust performance, with a 3.0% increase over the last week and a substantial 26% rise in the past year, as earnings are projected to grow by 16% annually. In this thriving environment, identifying dividend stocks that offer both reliable income and potential for growth can be an effective strategy for investors looking to capitalize on these favorable conditions.
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

A Look At UFP Technologies (UFPT) Valuation After Recent Share Price Moves

Why UFP Technologies is on investors’ radar today Recent share price moves in UFP Technologies (UFPT), including a 6.2% gain over the past day and negative returns over the month and past 3 months, have drawn fresh attention to the medical packaging specialist. See our latest analysis for UFP Technologies. That 6.25% 1 day share price return has come after a weaker patch, with a 30 day share price return of 6.75% and a 90 day share price return of 21.51%. The 1 year total shareholder return...
NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

How Barclays’ Cautious Overweight Call Ahead of Q1 Results At SLM (SLM) Has Changed Its Investment Story

On April 6, 2026, Barclays analyst Terry Ma reaffirmed an "Overweight" rating on SLM Corporation while adopting a more cautious outlook on the company. This shift in analyst sentiment, combined with upcoming first-quarter 2026 results announced for April 23, 2026, is prompting investors to reassess SLM's prospects. Now we’ll consider how Barclays’ more cautious stance, despite retaining a positive rating, may influence SLM’s existing investment narrative. The best AI stocks today may lie...
NYSE:DAL
NYSE:DALAirlines

Delta Air Lines Q1 Loss Tests Bullish Margin Narrative Despite Strong Trailing Profitability

Delta Air Lines (DAL) opened 2026 with Q1 revenue of US$15.9b and a basic EPS loss of US$0.44, as net income swung to a loss of US$289m against a strong Q4 2025, when the company posted revenue of US$16.0b and basic EPS of US$1.88. Over the past year, revenue on a trailing basis has held near US$65.2b while basic EPS moved to US$6.89, and the trailing net profit margin of 6.9% sits above last year’s 5.9%. This provides a clearer view of how margins are trending through the current soft...